Litcius/Paper detail

Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial

Jean‐Christophe Richard, Nicolas Terzi, Hodane Yonis, Fatima Chorfa, Florent Wallet, Claire Dupuis, Laurent Argaud, Bertrand Delannoy, Guillaume Thiéry, Christian Pommier, Paul Abraham, Michel Müller, Florian Sigaud, Guillaume Rigault, Emilie Joffredo, Mehdi Mezidi, Bertrand Souweine, Loredana Baboi, Hassan Serrier, Muriel Rabilloud, Laurent Bitker, Gaël Bourdin, Emmanuel Vivier, Audrey Large, Pierre‐Yves Donzé, Radhia Bouzgarrou, Sophie Perinel Ragey, Caroline Chaudier, Olivier Desebbe, Laure Folliet, Louis Chauvelot, Paul Chabert, Guillaume David, William Danjou, Clotilde BETTINGER, Pauline Bernon, François Dhelft, Martin Cour, Marie Simon, Thomas Baudry, Thomas Rimmelé, Jean-François Carabalona, Arnaud Grégoire, Arnaud Friggeri, Donatien De‐Marignan, Sylvain Roche

2023The Lancet Respiratory Medicine31 citationsDOI

Topics & Concepts

ARDSMedicineTidal volumeMechanical ventilationVentilation (architecture)Randomized controlled trialFraction of inspired oxygenAnesthesiaIntensive careInternal medicineLungRespiratory systemIntensive care medicineEngineeringMechanical engineeringRespiratory Support and MechanismsCOVID-19 Clinical Research StudiesSepsis Diagnosis and Treatment
Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial | Litcius